West Pharmaceutical Services has solidified its position as a leader in the primary packaging sector for injectable medicines, having been recognized as the Best Primary Packaging Specialist in 2024. Headquartered in Pennsylvania, USA, West plays a crucial role in the global pharmaceutical supply chain, delivering an astonishing 43 billion components and devices annually.

In 2023, the company reported net sales of $2.95 billion, showcasing steady growth driven by its comprehensive offerings that span containment, drug delivery systems, and integrated services. With over 10,000 employees worldwide, West's expansive infrastructure supports clients across every stage of the drug development and commercialization process.

West’s expertise is not limited to manufacturing components. Its value-added services include analytical support, regulatory consulting, fill-finish operations, contract manufacturing, and sophisticated packaging solutions. These services make the company a preferred partner for pharmaceutical and biotech firms aiming to navigate the increasingly complex regulatory landscape and patient-centric product delivery models.

A key strength of West lies in its pioneering work around extractables and leachables (E&L), critical factors when assessing material compatibility with sensitive drug formulations. Industry expert Diane Paskiet, a prominent voice within West, has frequently addressed the topic, underlining the company’s leadership in ensuring product integrity and patient safety.

In a strategic move to support the next generation of therapies, West launched its Daikyo Crystal Zenith (CZ) Nested Vials in Tub in 2024. This innovative packaging platform is specifically designed for cell and gene therapies, radiopharmaceuticals, and other sensitive biologics. The CZ material is a high-performance cyclic olefin polymer known for its excellent barrier properties, low risk of interaction with drugs, and break resistance—addressing many of the limitations of traditional glass vials.

The recognition of West's commitment goes beyond technical excellence. In 2024, the company was honored with the Heart of Pharma Award at CPhI, in recognition of its philanthropic and community-oriented initiatives, especially its impactful partnership with the Fox Chase Cancer Center in Pennsylvania. This award celebrates companies that align business practices with ethical and social responsibility.

Further highlighting its dedication to inclusive workplace culture, Newsweek and the Plant-A Insights Group named West one of America’s Greatest Workplaces for Diversity in February 2024. This accolade reflects the company’s efforts to foster a diverse and equitable environment that empowers innovation and excellence across all levels of its global operations.

From advanced polymer-based packaging to community partnerships, West Pharmaceutical Services continues to redefine industry benchmarks—earning not just trust, but admiration from its peers and partners.